Appia Bio

Appia Bio

Appia Bio is a biotechnology startup dedicated to discovering and developing scalable allogeneic cell therapies to increase access to cancer treatment. Market:Cell therapy has brought dramatic improvements in efficacy and durable remission rates in certain...
Avesta76 Therapeutics

Avesta76 Therapeutics

  Avesta76 is focused on a target that has the potential to treat every type of tumor. Market: Avesta76's therapies will address the need for safe and effective treatments across multiple cancers. This is a market with 17 million annual diagnoses, 10 million deaths,...
Myst Therapeutics

Myst Therapeutics

Myst Therapeutics, Inc. is developing novel cancer immunotherapy products designed to harness the power of a patient’s own immune system to destroy solid tumor cancer cells. Market:Over 400,000 Americans die from cancer every year, with roughly 10% being blood cancers...